Boston Scientific Acquires NxThera for $406 Million

Posted in Medical Device

March 21, 2018 • 3 min read

The rumors have been discussed for two years that Boston Scientific would acquire NxThera, the developer of Rezum, a minimally invasive therapy that treats BPH (benign prostatic hyperplasia). Today Boston Scientific made it official, acquiring NxThera...